Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial

被引：16

作者：

Bahlis, Nizar J. ^{[1
,2
]}

Kotb, Rami ^{[3
]}

Sebag, Michael ^{[4
]}

Sutherland, Heather J. ^{[5
]}

LeBlanc, Richard ^{[6
]}

White, Darrell ^{[7
]}

Venner, Christopher P. ^{[8
]}

Kouroukis, Tom ^{[9
]}

Bergstrom, Debra ^{[10
]}

McCurdy, Arleigh ^{[11
]}

Lalancette, Marc ^{[12
]}

Bensinger, William ^{[13
]}

Lentzsch, Suzanne ^{[14
]}

Del Col, Aldo ^{[15
]}

Kauffman, Michael ^{[16
]}

Shacham, Sharon ^{[16
]}

Jeha, Jacqueline ^{[16
]}

Picklesimer, Carla ^{[16
]}

Saint-Martin, Jean-Richard ^{[16
]}

Choe-Juliak, Cassandra ^{[16
]}

Chen, Christine ^{[17
]}

机构：

[1] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[2] Univ Calgary, Calgary, AB, Canada

[3] Univ Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada

[4] McGill Univ Hlth Ctr, Montreal, PQ, Canada

[5] Vancouver Gen Hosp, Vancouver, BC, Canada

[6] Maisonneuve Rosemont Hosp, Dept Medecine, Serv Hematol & Med Oncol, Montreal, PQ, Canada

[7] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[8] Cross Canc Inst, Edmonton, AB, Canada

[9] Juravinski Canc Ctr, Hamilton, ON, Canada

[10] Mem Hosp Newfoundland, St John, NF, Canada

[11] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[12] Hotel Dieu Quebec, Quebec City, PQ, Canada

[13] Swedish Canc Inst, Myeloma & Transplant Program, Seattle, WA USA

[14] Columbia Univ Med Ctr, Div Hematol Oncol, New York, NY USA

[15] Myeloma Canada, Montreal, PQ, Canada

[16] Karyopharm Therapeutics Inc, Newton, MA USA

[17] Princess Margaret Canc Ctr, Dept Med Oncol & Hemato, Toronto, ON, Canada

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.977.977

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

977

引用

页数：7